Cancer Immunotherapy Trials Network

Scientific Leadership

Martin "Mac" Cheever, MD Principal Investigator of the CITN

Dr. Cheever is the Principal Investigator at CITN responsible for the Central Operations & Statistical Center (COSC). He is also the Director of the Solid Tumor Research for the Fred Hutchinson Cancer Research Center (FHCRC).

Read more

Mary L. “Nora” Disis, MD, Co-Investigator of the CITN

Dr. Disis is the Co-Investigator responsible for immune monitoring. Dr. Disis is the Associate Dean for Translational Health Sciences in the UW School of Medicine, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at UW.

Read more

Kim Margolin, MD, Co-Investigator of the CITN

Dr. Margolin has shared responsibility for organization & trial development at CITN. Dr. Margolin joined Seattle Cancer Care Alliance as a Professor at the University of Washington and a member of the Fred Hutchinson Cancer Research Center.

Read more

John Thompson, MD , CITN Consultant – Phase I/II protocol design

Dr. Thompson is a University of Washington professor , Medical Oncology Division,. He is the director Phase I Clinical Trials Program at Seattle Cancer Care Alliance and member of clinical trial division at the Fred Hutchinson Cancer Research Center.

Read more

Francesco Marincola, MD, FACS –CITN Consultant, Immune monitoring

Dr. Marincola is Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the NIH in Bethesda. Dr Marincola will consult on the scientific and quality control of immune monitoring aspects of the CITN.

Read more

Anna Karolina Palucka, MD, PhD, CITN Consultant

Analysis of blood transcriptional profiles and biomarker signatures

Dr. Palucka is an Investigator, Baylor Institute for Immunology Research, Dallas, Texas and a Professor, Department of Gene & Cell Medicine, Mt. Sinai School of Medicine.

Read more